Operating Company Healthcare

Envision Pharma Group

London, United Kingdom

Founded in 2001, Envision Pharma Group is a global technology-enabled strategic solutions partner for the life sciences industry. It provides medical affairs and medical communications capabilities (including patient engagement and publication planning/delivery), integrated technology and data analytics, and evidence-based scientific communications across the product lifecycle.

Focus Areas
Medical affairs, Medical communications, HEOR / market access

Tracked deals

4

4 tracked deals across 2020-2023.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Addon

4 addon

Envision Pharma Group Acquisition Volume by Year

Last 3 years

Acquisition volume by year Annual acquisition counts for the last 3 years for Envision Pharma Group. 2 2020 1 2021 1 2023

Supporting Data

Recent Transactions

  • Envision Pharma Group Acquires OKRA.ai
    February 8, 2023
    Buyer
    Envision Pharma Group
    Target
    OKRA.ai
    Industry
    AI & Machine Learning
    Location
    United Kingdom
    Type
    Addon

    Envision Pharma Group, a portfolio company of GHO Capital, has acquired OKRA.ai, an award-winning AI technology provider for the life sciences industry. The add-on expands Envision's technology-enabled capabilities in AI, real-world evidence and data analytics to better support pharmaceutical and biotech clients across the product lifecycle.

  • Envision Pharma Group Acquires doDOC
    March 22, 2021
    Buyer
    Envision Pharma Group, GHO Capital Partners LLP
    Target
    doDOC Corp.
    Industry
    Software
    Location
    Massachusetts, United States
    Type
    Addon

    Envision Pharma Group, a portfolio company of GHO Capital Partners, has acquired doDOC Corp., a Boston-founded SaaS platform for collaborative document review and authoring tailored to the life sciences. doDOC will operate as a business unit under its existing brand and be integrated into Envision's iEnvision medical affairs platform to expand document collaboration capabilities and improve workflow efficiency.

  • Envision Pharma Group Acquires Two Labs
    November 12, 2020
    Buyer
    Envision Pharma Group
    Target
    Two Labs
    Seller
    Excellere Partners
    Industry
    Healthcare Services
    Location
    Ohio, United States
    Type
    Addon

    Envision Pharma Group has acquired Two Labs, a Powell, Ohio-based provider of pharmaceutical commercialization, launch planning, market access and market intelligence services. The deal, which follows increased investment in Envision from GHO Capital, strengthens Envision's US presence and expands its launch-excellence capabilities; Excellere Partners will exit its investment in Two Labs.

  • Envision Pharma Group Acquires 90TEN
    April 8, 2020
    Buyer
    Envision Pharma Group, Ardian, GHO Capital Partners LLP
    Target
    90TEN
    Industry
    Healthcare Services
    Location
    England, United Kingdom
    Type
    Addon

    Envision Pharma Group, a portfolio company backed by Ardian and GHO Capital, has acquired London-based healthcare communications consultancy 90TEN. 90TEN will retain its brand and management, bringing behavioral science-led communications capabilities to Envision's global medical affairs and communications offerings.

Related Acquisition Pages

Healthcare Services Buyers & Acquisitions 2 tracked deals by Envision Pharma Group. AI & Machine Learning Buyers & Acquisitions 1 tracked deal by Envision Pharma Group. Software Buyers & Acquisitions 1 tracked deal by Envision Pharma Group. Acquisitions in Massachusetts 1 tracked deal by Envision Pharma Group. Acquisitions in Ohio 1 tracked deal by Envision Pharma Group.

Related articles

Selling a company? Get in front of buyers like Envision Pharma Group

Turn tracked acquisition activity into an outreach-ready buyer list.

Find buyers like these →